OPEN, LAPAROSCOPIC AND TRANSANAL TOTAL MESORECTAL EXCISION: A SYSTEMATIC LITERATURE REVIEW AND NETWORK META ANALYSIS

AIM: to compare the effectiveness of different methods of total mesorectumectomy (TME).

MATERIALS AND METHODS: the systematic review performed in accordance with PRISMA practice and recommendations.

RESULTS: Forty-one papers were included in the analysis. Fourteen studies were for transanal total mesorectumectomy (TA TME) (n=480) compared with laparoscopic (LA TME), 26 – for LA TME vs open (n=6820), 1 – for open vs TA TME. There was no significant difference between open TME, LA TME and TA TME in grade 3 quality of mesorectumectomy by Quirke. The positive circular resection margin (CRM) is less often in TA TME group, then LA TME (OR=2.58, CI 1.34-4.97, p=0.005). There was significantly lower positive CRM rate in LA TME then open TME (OR=0.73, CI 0.63-0.85, p<0.0001). There were no significant differences in postoperative complications rates between LA TME and TA TME (p=0.72). Network meta-analysis showed less postoperative complications followed LA TME than open TME (OR=0.75, CI 0.65-0.84).

CONCLUSION: TA TME is comparable with laparoscopic and open TME in short term results. Rates of positive CRM, the quality of Grade 1 mesorectal excision, the conversion rate, the postoperative urinary dysfunction, may have better results in TA TME.

1. Heald RJ, Moran B, Ryall R. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Archives of surgery (Chicago, Ill. : 1960). 1998; 8(133):894-899.

2. Kazieva L.Yu. Transanal total mesorectal excision for rectal cancer (review). Koloproktologia. 2016; no. 2(56), pp. 57-64. (in Russ.)

3. Jayne DG, Thorpe HC, Copeland J. Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. The British journal of surgery. 2010;11 (97):1638-1645.

4. Jeong S-Y, Park JW, Nam BH. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemora-diotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. The Lancet. Oncology. 2014;7 (15):767-774.

5. Gunka I, Dostalik J, Martinek L. Long-term results of laparoscopic versus open surgery for nonmetastatic colorectal cancer. Acta chirurgica Belgica. 2012;2(112):139-147.

6. Kellokumpu IH, Kairaluoma MI, Nuorva KP. Short- and long-term outcome following laparoscopic versus open resection for carci-noma of the rectum in the multimodal setting. Diseases of the colon and rectum. 2012; 8 (55):854-863.

7. Xia X, Huang C, Jiang T. Is laparoscopic colorectal cancer surgery associated with an increased risk in obese patients? A retrospective study from China. World journal of surgical oncology. 2014;(12):184.

8. Lelong B, Meillat H, Zemmour C. Short- and Mid-Term Outcomes after Endoscopic Transanal or Laparoscopic Transabdominal Total Mesorectal Excision for Low Rectal Cancer: A Single Institutional Case-Control Study. Journal of the American College of Surgeons. 2017;5 (224):917-925.

9. Perdawood SK, Al Khefagie GA. Transanal vs laparoscopic total mesorectal excision for rectal cancer: initial experience from Denmark. Colorectal disease: the official journal of the Association of Coloproctology of Great Britain and Ireland. 2016;1(18):51-58.

10. Kazieva L.Yu. Transanal total mesorectal excision for rectal cancer: dis. … kand. med. nauk: 14.01.17: 27.10.16. (in Russ.)

11. Chen C-C, Lai Y-L, Jiang J-K. Transanal Total Mesorectal Excision Versus Laparoscopic Surgery for Rectal Cancer Receiving Neoadjuvant Chemoradiation: A Matched Case-Control Study. Annals of surgical oncology. 2016;4(23): 1169-1176.

12. Perdawood SK, Thinggaard BS, Bjoern MX. Effect of transanal total mesorectal excision for rectal cancer: comparison of short-term outcomes with laparoscopic and open surgeries. Surgical endoscopy. 2017;32(5):2312-2321.

13. Velthuis S, van den Boezem PB, van der Peet DL. Transanal versus traditional laparoscopic total mesorectal excision for rectal carcinoma. Surgical endoscopy. 2014;12 (28):3494-3499.

14. Liberati A, Altman D, Tetzlaff J. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clinical research ed.). 2009; (339), p. b2700.

15. Wheeler DC, Hickson DA, Waller LA. Assessing Local Model Adequacy in Bayesian Hierarchical Models Using the Partitioned Deviance Information Criterion. Computational statistics & data analysis. 2010;6 (54):1657-1671.

16. Denost Q, Loughlin P, Chevalier R. Transanal versus abdominal low rectal dissection for rectal cancer: long-term results of the Bordeaux’ randomized trial. Surgical endoscopy. 2018;32(3):1486-1494.

17. de’Angelis N, Portigliotti L, Azoulay D. Transanal total mesorec-tal excision for rectal cancer: a single center experience and sys-tematic review of the literature. Langenbeck’s archives of surgery. 2015;8(400):945-959.

18. Fernandez-Hevia M, Delgado S, Castells A. Transanal total meso-rectal excision in rectal cancer: short-term outcomes in comparison with laparoscopic surgery. Annals of surgery. 2015;2(261):221-227.

19. Marks JH, Montenegro GA, Salem JF. Transanal TATA/TME: a case-matched study of taTME versus laparoscopic TME surgery for rectal cancer. Techniques in coloproctology. 2016;7 (20):467-473.

20. Rasulov AO, Mamedli ZZ, Gordeyev SS. Short-term outcomes after transanal and laparoscopic total mesorectal excision for rectal cancer. Techniques in coloproctology. 2016;4 (20):227-234.

21. Chouillard E, Regnier A, Vitte R-L. Transanal NOTES total meso-rectal excision (TME) in patients with rectal cancer: Is anatomy better preserved? Techniques in coloproctology. 2016; 8(20):537-544.

22. Chang T-C, Kiu K-T. Transanal Total Mesorectal Excision in Lower Rectal Cancer: Comparison of Short-Term Outcomes with Conventional Laparoscopic Total Mesorectal Excision. Journal of laparoendoscopic & advanced surgical techniques. Part A. 2018;4(28): 365-369.

23. Mege D, Hain E, Lakkis Z. Is trans-anal total mesorectal excision really safe and better than laparoscopic total mesorectal excision with a perineal approach first in patients with low rectal cancer? A learning curve with case-matched study in 68 patients. Colorectal disease: the official journal of the Association of Coloproctology of Great Britain and Ireland. 2018;6 (20):O143–O151.

24. Persiani R, Biondi A, Pennestri F. Transanal Total Mesorectal Excision vs Laparoscopic Total Mesorectal Excision in the Treatment of Low and Middle Rectal Cancer: A Propensity Score Matching Analysis. Diseases of the colon and rectum. 2018;7 (61):809-816.

25. Veltcamp Helbach M, Koedam TWA., Knol JJ. Quality of life after rectal cancer surgery: differences between laparoscopic and trans-anal total mesorectal excision. Surgical endoscopy. 2018;33(1):79-87.

26. Wu Y, Sun X, Qi J. Comparative study of short- and long-term outcomes of laparoscopic-assisted versus open rectal cancer resec-tion during and after the learning curve period. Medicine. 2017;19 (96): e6909.

27. Baik SH, Gincherman M, Mutch MG. Laparoscopic vs open resec-tion for patients with rectal cancer: comparison of perioperative outcomes and long-term survival. Diseases of the colon and rectum. 2011; 1(54): 6-14.

28. Kang S-B, Jeong S-Y, Park JW. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. The Lancet. Oncology. 2010;7 (11): 637-645.

29. Pas MH van der, Haglind E, Cuesta M. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a ran-domised, phase 3 trial. The Lancet. Oncology. 2013;3 (14):210-218.

30. Stevenson ARL, Solomon MJ, Lumley JW. Effect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer: The ALaCaRT Randomized Clinical Trial. JAMA. 2015;13 (314):1356-1363.

31. Fleshman J, Branda M, Sargent DJ. Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial. JAMA. 2015;13(314):1346-1355.

32. Gouvas N, Tsiaoussis J, Pechlivanides G. Laparoscopic or open surgery for the cancer of the middle and lower rectum short-term outcomes of a comparative non-randomised study. International journal of colorectal disease. 2009;7(24):761-769.

33. Kim JH, Ahn BK, Park SJ. Long-term Outcomes of Laparoscopic versus Open Surgery for Rectal Cancer: A Singlecenter Retrospective Analysis. The Korean Journal of Gastroenterology. 2015;5 (65):273.

34. Cho MS, Kim CW, Baek SJ. Minimally invasive versus open total mesorectal excision for rectal cancer: Long-term results from a case-matched study of 633 patients. Surgery. 2015; 6(157): 1121-1129.

35. McKay GD, Morgan MJ, Wong S-KC. Improved short-term out-comes of laparoscopic versus open resection for colon and rectal cancer in an area health service: a multicenter study. Diseases of the colon and rectum. 2012;1 (55): 42-50.

36. Breukink SO, Pierie JPEN, Grond AJK. Laparoscopic versus open total mesorectal excision: a case-control study. International jour-nal of colorectal disease. 2005; 5(20):428-433.

37. Khaikin M, Bashankaev B, Person B. Laparoscopic versus open proctectomy for rectal cancer: patients’ outcome and oncologic adequacy. Surgical laparoscopy, endoscopy & percutaneous tech-niques. 2009;2 (19):118-122.

38. Laurent C, Leblanc F, Wutrich P. Laparoscopic versus open surgery for rectal cancer: long-term oncologic results. Annals of surgery. 2009; 1(250):54-61.

39. Law WL, Lee YM, Choi HK. Laparoscopic and open anterior resec-tion for upper and mid rectal cancer: an evaluation of outcomes. Diseases of the colon and rectum. 2006;8(49):1108-1115.

40. Lelong B, Bege T, Esterni B. Short-term outcome after laparo-scopic or open restorative mesorectal excision for rectal cancer: a comparative cohort study. Diseases of the colon and rectum. 2007;2 (50):176-183.

41. Leung KL, Kwok SPY., Lau WY. Laparoscopic-assisted abdomino-perineal resection for low rectal adenocarcinoma. Surgical endos-copy. 2000;1 (14):67-70.

42. Liang X, Hou S, Liu H. Effectiveness and safety of laparoscopic resection versus open surgery in patients with rectal cancer: a ran-domized, controlled trial from China. Journal of laparoendoscopic & advanced surgical techniques. Part A. 2011;5 (21):381-385.

43. Lujan J, Valero G, Hernandez Q. Randomized clinical trial comparing laparoscopic and open surgery in patients with rectal cancer. The British journal of surgery. 2009;9 (96):982-989.

44. Lujan J, Valero G, Biondo S. Laparoscopic versus open surgery for rectal cancer: results of a prospective multicentre analysis of 4,970 patients. Surgical endoscopy. 2013;1 (27):295-302.

45. Morino M, Allaix M, Giraudo G Laparoscopic versus open surgery for extraperitoneal rectal cancer: a prospective comparative study. Surgical endoscopy. 2005;11 (19):1460-1467.

46. Strohlein MA, Grutzner K-U, Jauch K-W. Comparison of lapa-roscopic vs. open access surgery in patients with rectal cancer: a prospective analysis. Diseases of the colon and rectum. 2008;4 (51):385-391.

47. Veenhof AAFA, Engel AF, Craanen ME. Laparoscopic versus open total mesorectal excision: a comparative study on short-term out-comes. A single-institution experience regarding anterior resec-tions and abdominoperineal resections. Digestive surgery. 2007;5 (24):367-374.

48. Braga M, Frasson M, Vignali A. Laparoscopic resection in rectal cancer patients: outcome and cost-benefit analysis. Diseases of the colon and rectum. 2007;4(50):464-471.comparison with laparoscopic surgery. Annals of surgery. 2015;2 (261): 221-227.

49. Ng SSM, Leung KL, Lee JFY. Laparoscopic-assisted versus open abdominoperineal resection for low rectal cancer: a prospective randomized trial. Annals of surgical oncology. 2008; 9 (15):2418-2425.

50. Ng SSM, Lee JFY, Yiu RYC. Laparoscopic-assisted versus open total mesorectal excision with anal sphincter preservation for mid and low rectal cancer: a prospective, randomized trial. Surgical endoscopy. 2014;1 (28):297-306.

51. Garcia-Granero E, Faiz O, Munoz E. Macroscopic assessment of mesorectal excision in rectal cancer: a useful tool for improv-ing quality control in a multidisciplinary team. Cancer. 2009;15 (115):3400-3411.

52. Quirke P, Steele R, Monson J. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal can-cer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet (London, England). 2009; 9666 (373):821-828.

53. Fleshman J, Branda M, Sargent DJ. Disease-free Survival and Local Recurrence for Laparoscopic Resection Compared With Open Resection of Stage II to III Rectal Cancer: Follow-up Results of the ACOSOG Z6051 Randomized Controlled Trial. Annals of surgery. 2019;269(4):589-595.

54. Motson R, Whiteford M, Hompes R. Current status of trans-anal total mesorectal excision (TaTME) following the Second International Consensus Conference. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2016;1 (18):13-18.

55. Lacy AM, Tasende MM, Delgado S. Transanal Total Mesorectal Excision for Rectal Cancer: Outcomes after 140 Patients. Journal of the American College of Surgeons. 2015;2 (221):415-423.

56. Veltcamp Helbach M, Koedam TWA, Knol JJ. Residual meso-rectum on postoperative magnetic resonance imaging following transanal total mesorectal excision (TaTME) and laparoscopic total mesorectal excision (LapTME) in rectal cancer. Surgical endoscopy. 2019;33(1):94-102.